Pharmaceutical composition for solubility enhancement of hydrophobic drugs

Details for Australian Patent Application No. 2004255459 (hide)

Owner Sandoz AG

Inventors Davila, Pablo; Ray, Anup Kumar; Nandi, Indranil; Vora, Aakanksha Harshad; Palaniswamy, Suresh

Agent Davies Collison Cave

Pub. Number AU-A-2004255459

PCT Pub. Number WO2005/004917

Priority 10/618,545 11.07.03 US

Filing date 9 July 2004

Wipo publication date 20 January 2005

International Classifications

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/004917 Priority application(s): WO2005/004917

24 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255466-Pharmaceutical formulation comprising levothyroxine sodium

2004255458-Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form